Approval · Notice of Compliance 13024 · 2012
AXID: Notice of Compliance 13024
Issued February 10, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13024
- Date
- February 10, 2012
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Histamine H2 Receptor Antagonist
Products in this notice
Medicinal ingredients
- NIZATIDINE 150 MG per CAP
- NIZATIDINE 300 MG per CAP